E-Mail Us Close
Please note that this email should only be used for feedback and comments specifically related to this particular medical policy.
  
Horizon BCBSNJ
Uniform Medical Policy ManualSection:D M E
Policy Number:017
Effective Date: 03/14/2019
Original Policy Date:08/07/1996
Last Review Date:04/14/2020
Date Published to Web: 03/14/2019
Subject:
Continuous Passive Motion Device

Description:
_______________________________________________________________________________________

IMPORTANT NOTE:

The purpose of this policy is to provide general information applicable to the administration of health benefits that Horizon Blue Cross Blue Shield of New Jersey and Horizon Healthcare of New Jersey, Inc. (collectively “Horizon BCBSNJ”) insures or administers. If the member’s contract benefits differ from the medical policy, the contract prevails. Although a service, supply or procedure may be medically necessary, it may be subject to limitations and/or exclusions under a member’s benefit plan. If a service, supply or procedure is not covered and the member proceeds to obtain the service, supply or procedure, the member may be responsible for the cost. Decisions regarding treatment and treatment plans are the responsibility of the physician. This policy is not intended to direct the course of clinical care a physician provides to a member, and it does not replace a physician’s independent professional clinical judgment or duty to exercise special knowledge and skill in the treatment of Horizon BCBSNJ members. Horizon BCBSNJ is not responsible for, does not provide, and does not hold itself out as a provider of medical care. The physician remains responsible for the quality and type of health care services provided to a Horizon BCBSNJ member.

Horizon BCBSNJ medical policies do not constitute medical advice, authorization, certification, approval, explanation of benefits, offer of coverage, contract or guarantee of payment.

__________________________________________________________________________________________________________________________

Continuous passive motion (CPM) devices are used to keep a joint in motion without patient assistance. CPM is being evaluated for treatment and postsurgical rehabilitation of the upper- and lower-limb joints and for a variety of musculoskeletal conditions.

PopulationsInterventionsComparatorsOutcomes
Individuals:With total knee arthroplastyInterventions of interest are:Continuous passive motion in the home settingComparators of interest are:Physical therapy aloneStandard of care, if unable to tolerate physical therapyRelevant outcomes include:SymptomsFunctional outcomes
Individuals:With articular cartilage repair of the kneeInterventions of interest are:Continuous passive motion in the home settingComparators of interest are:Standard of careRelevant outcomes include:SymptomsFunctional outcomes
Individuals:With musculoskeletal conditions other than total knee arthroplasty or knee cartilage repair requiring physical therapyInterventions of interest are:Continuous passive motion in the home settingComparators of interest are:Standard of careRelevant outcomes include:SymptomsFunctional outcomes
Individuals:Who have had a stroke requiring physical therapyInterventions of interest are:Continuous passive motion in the home settingComparators of interest are:Standard of careRelevant outcomes include:SymptomsFunctional outcomes

BACKGROUND

Physical therapy of joints following surgery focuses both on passive motion to restore mobility and on active exercises to restore strength. While passive motion can be administered by a therapist, continuous passive motion (CPM) devices have also been used. CPM is thought to improve recovery by stimulating the healing of articular tissues and the circulation of synovial fluid; reducing local edema; and preventing adhesions, joint stiffness or contractures, or cartilage degeneration. CPM has been investigated primarily in the knee, particularly after total knee arthroplasty or ligamentous or cartilage repair. Acceptance of its use in the knee joint has created interest in CPM use for other weight-bearing joints (ie, hip, ankle, metatarsals) as well as non-weight-bearing joints (ie, shoulder, elbow, metacarpals, interphalangeal joints). Use of CPM in stroke and burn patients is also being explored.

The device used for the knee moves the joint (eg, flexion and extension) without patient assistance, continuously for extended periods of time (ie, up to 24 h/d). An electrical power unit is used to set the variable range of motion (ROM) and speed. The initial settings for ROM are based on a patient’s level of comfort and other factors assessed intraoperatively. The ROM is increased by three to five per day, as tolerated. The speed and ROM can be varied, depending on joint stability. The use of the device may be initiated in the immediate postoperative period and then continued at home for a variable period of time.

Over time, hospital lengths of stay have progressively shortened and, in some cases, surgical repair is done as an outpatient or with a length of stay of one to two days. As a result, there has been a considerable shift in the rehabilitation regimen, moving from an intensive in-hospital program to a less intensive outpatient program. Some providers may want patients to continue CPM in the home setting as a means of duplicating services offered with a longer (7-day) hospital stay.

The focus of the current review is to examine the literature on the use of CPM in the home setting as it is currently being prescribed postoperatively. Relevant comparisons are treatment outcomes of CPM when used alone or with physical therapy, compared with physical therapy alone.

Regulatory Status

CPM devices are considered class I devices by the U.S. Food and Drug Administration and are exempt from 510(k) requirements. This classification does not require submission of clinical data on efficacy but only notification of the Food and Drug Administration prior to marketing. Food and Drug Administration product code: BXB.

Related Policies

  • Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions (Policy #013 in the Surgery Section)
  • Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions (Policy #064 in the Surgery Section)

Policy:
(NOTE: For Medicare Advantage, Medicaid and FIDE-SNP, please refer to the Coverage Sections below for coverage guidance.)

1. The Continuous Passive Motion (CPM) device must be ordered by the treating physician.

2. A CPM (E0935) device is medically necessary for any of the following situations:

    • following total knee arthroplasty or revision
    • following anterior cruciate ligament (ACL) reconstruction
    • following knee joint arthroscopy with tendon and/or joint repair

3. In general, a CPM device should be utilized in the immediate (i.e., within 48 hours) post-operative period. However, in circumstances where it is not possible to utilize the device within 48 hours (e.g., due to post-operative pain, no progress/slow progress in range of motion (ROM) after surgery, etc.), special consideration may be given and exceptions made based on medical necessity.

4. When use of a CPM device is medically necessary, it may generally be rented for four (4) weeks. Medical necessity must be established for its continued use beyond the 4-week period.

5. CPM device for other conditions is not medically necessary and thus, not eligible for reimbursement since it has not been proven to provide equivalent or superior benefit compared to conventional physical therapy.


Medicare Coverage:
Per National Coverage Determination (NCD) for Durable Medical Equipment Reference List 280.1, a continuous passive motion (CPM) device is covered following total knee replacement surgery when the onset of use is within two days following the surgical procedure. Coverage is limited to that portion of the three-week period following the surgical procedure where the device is used in the beneficiary's home. Use of the device for longer than the three-week post-operative period or use for other than total knee replacement/revision will be denied. For additional information regarding coverage and eligibility, refer to NCD 280.1. Available at: https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=190&ncdver=2&bc=AgAAgAAAAAAAAA%3d%3d&.


Medicaid Coverage:
For members enrolled in Medicaid and NJ FamilyCare plans, Horizon BCBSNJ applies the above medical policy.

FIDE-SNP Coverage:

For members enrolled in a Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP): (1) to the extent the service is covered under the Medicare portion of the member’s benefit package, the above Medicare Coverage statement applies; and (2) to the extent the service is not covered under the Medicare portion of the member’s benefit package, the above Medicaid Coverage statement applies.



[RATIONALE: This policy was created in 1996 and has been updated regularly with searches of the MEDLINE database. The most recent literature update was performed through January 6, 2019.

Evidence reviews assess the clinical evidence to determine whether the use of technology improves the net health outcome. Broadly defined, health outcomes are the length of life, quality of life, and ability to functionincluding benefits and harms. Every clinical condition has specific outcomes that are important to patients and managing the course of that condition. Validated outcome measures are necessary to ascertain whether a condition improves or worsens; and whether the magnitude of that change is clinically significant. The net health outcome is a balance of benefits and harms.

To assess whether the evidence is sufficient to draw conclusions about the net health outcome of technology, two domains are examined: the relevance, and quality and credibility. To be relevant, studies must represent one or more intended clinical use of the technology in the intended population and compare an effective and appropriate alternative at a comparable intensity. For some conditions, the alternative will be supportive care or surveillance. The quality and credibility of the evidence depend on study design and conduct, minimizing bias and confounding that can generate incorrect findings. The randomized controlled trial (RCT) is preferred to assess efficacy; however, in some circumstances, nonrandomized studies may be adequate. RCTs are rarely large enough or long enough to capture less common adverse events and long-term effects. Other types of studies can be used for these purposes and to assess generalizability to broader clinical populations and settings of clinical practice.

Total Knee Arthroplasty

Early Postoperative In-Hospital Setting

Systematic Reviews

This policy was informed by a TEC Assessment (1997) that concluded continuous passive motion (CPM) met the TEC criteria as an adjunct to physical therapy (PT) in patients undergoingTKA.1, Early studies of CPM machines focused on their use in the hospital setting, in which the impact on length of stay was frequently considered a key clinical outcome, and so the TEC Assessment did not specifically examine the point of service or the length of time CPM devices were used. A critical study identified in the TEC Assessment was an RCT by McInnes et al (1992) that compared use of CPM initiated in the immediate postoperative period and continued through the 7-day hospital stay with standard rehabilitation alone.2, At six weeks postoperatively, the most salient difference between groups was an increased incidence of arthrofibrosis requiring manipulation in the non-CPM group.

Efficacy in the early postoperative period has been cited as a reason to support the continued use of these devices in the non-acute care hospital or home setting following early discharge. CPM after TKA was the subject of a 2003 Cochrane review.3, Reviewers reported that CPM combined with PT significantly increased active knee flexion and decreased length of stay. However, the analysis suggested the benefits of CPM in a hospital setting may be small and only short-term.4, This Cochrane review was updated in 2010 and again in 2014.5,6, The updated review included 24 RCTs with 1445 participants and examined short-term (<6 weeks), medium-term (6 weeks to 6 months), and long-term (>6 months) effects of CPM. Most selected studies examined short-term effects. CPM was applied for 1.5 to 24 hours a day, over 1 to 17 days. A summary of findings is provided in Table 1.

Table 1. 2014 Cochrane Review Findings on CPM
Findings
QOE
CPM increases passive and active knee flexion range of motion (mean difference, 2), but the effects were too small to be clinically relevant
Moderate
CPM does not have clinically important short-term effects on pain (-0.4 points on a 10-point scale)
Low
CPM does not have clinically important medium-term effects on function or quality of life
Moderate
CPM may reduce the need for manipulation under anesthesia (25 fewer manipulations per 1000; RR=0.3)
Very low
CPM reduced the risk of adverse events (13 fewer adverse events per 1000, RR=0.9)
Low
Adapted from Harvey et al (2014).6, CPM: continuous passive motion; QOE: quality of evidence; RR: relative risk.

Another 2014 Cochrane systematic review, which included 11 RCTs, found no evidence that CPM reduced venous thromboembolism after TKA.7,

Randomized Controlled Trials

Yashar et al (1997) randomized 178 patients undergoing TKA to CPM immediately postsurgery or to CPM 1 day postsurgery.8, A small but statistically significant improvement in flexion was found at the time of discharge among those started on immediate CPM but this difference did not persist at four weeks. MacDonald et al (2000) reported on a randomized trial comparing immediate postoperative CPM with no CPM for 120 patients after TKA.9, Patients received a maximum of 24 hours with CPM. There were no differences between treatment groups in range of motion (ROM), length of stay, or analgesic requirements. In a trial reported by Pope et al (1997), 53 patients were randomized to 1 of 2 schedules of CPM (both for 48 hours) or to no CPM.10, The use of CPM was not associated with improved long-term function or ROM. Kumar et al (1996) randomized 73 patients who had undergone TKA to CPM immediately postsurgery or to a protocol of early passive flexion, referred to as the “drop and dangle” technique.11, Patients assigned to passive flexion were discharged from the hospital one day earlier and also had a statistically better extension range of 2.8 at six months than the CPM group.

Other RCTs have found that two to four hours of daily CPM in the hospital after TKA did not improve postoperative outcomes at discharge or follow-up.12,13,14,15, In 1 trial, Bruun-Olsen et al (2009) randomized 63 patients undergoing TKA to active PT exercises with or without CPM to assess any short-term benefit on pain or function.12, In both groups, exercises were performed daily for 30 minutes, starting 1 day after surgery and continuing until discharge at 1 week. For the experimental group, CPM was administered for four hours on the day of surgery, followed by six hours daily in addition to therapist-guided exercises. Blinded assessments at one week and three months after surgery showed similar results for pain and function in the two groups. At 1 week, both groups had visual analog scale (VAS) pain ratings of 40 and flexion scores within 2 of each other. Functional testing at threemonths showed no benefit of adjunctive CPM. The lack of improvement with CPM in these studies might have been attributable to patients mobilizing or commencing flexion immediately following surgery.14, A 2014 study of 150 patients undergoing TKA found no benefit of CPM when used over a 2-day postoperative hospital stay.15,

Non-Acute Care Hospital Setting

In an RCT, Herbold et al (2014) assessed 141 TKA patients assigned to daily conventional therapy lasting 3 hours or daily CPM for 2 hours throughout their inpatient rehabilitation stay.16, After an average length of stay of eight days, there were no significant differences between the CPM and no CPM groups for active ROM, Timed Up and Go test, knee girth, FIM scores, ambulation device at discharge, or on the self-reported Western Ontario and McMaster Universities Osteoarthritis Index scores.

Chen et al (2000) randomized 51 patients in an inpatient rehabilitation service who had undergone TKA to conventional active PT or to PT plus CPM.17, Referral to the rehabilitation center was made five to six days after surgery, and most had received CPM as part of the initial hospitalization. Knee flexion was the principal outcome. No significant differences were noted in passive ROM between the two groups, as measured on admission, on the third and seventh days, and at the time of discharge (eight days postadmission). Thus, the use of CPM in the rehabilitation hospital offered no added benefit.

In a 2012 retrospective comparative study, the same group as the Herbold et al (2014) RCT evaluated the use of CPM in 61 matched pairs of patients admitted to a rehabilitation hospital.18, Outcomes following use of CPM were compared with those from a cohort of 61 inpatients who also had poor initial ROM, defined as less than 75 of active knee flexion at the time of admission, and matched for postoperative day at admission, age, length of stay, and Health Insurance Prospective Payment System code. Use of CPM (2 h/d) was determined primarily by the referring physician and used in 29% of the pool of 633 patients who had poor initial ROM. Average length of stay was 7.85 days. There were no significant differences in outcomes at discharge, including knee flexion or extension, discharge to the community, need for home care services, need for an assistive device, or functional scores on the Health Insurance Prospective Payment System.

Home Setting

A study by Worland et al (1998) compared the use of CPM with active PT in the home setting. At discharge, they randomized 80 patients undergoing TKA to home CPM (3 h/d for 10 days) or to active PT.19, Most studies have examined CPM as an adjunct to active PT, while this study proposed CPM as an alternative to PT. At two weeks, knee flexion was similar in both groups but a flexion contracture was noted in one patient in the CPM group. At six months, no differences were found in knee scores or knee flexion.

In another RCT, Lenssen et al (2008) evaluated 60 patients with limited flexion ROM (<80) at the time of hospital discharge who were assigned to standard PT alone or PT plus CPM in the home (4 h/d) until assessment on postoperative day 17.20, Blinded assessment showed a trend for increased ROM for the CPM group (eg, 89 vs 84, respectively, p=0.07), with no differences in function between groups, as measured by the Knee Society Score (function subscore 43 vs 40, respectively) and the Western Ontario and McMaster Universities Osteoarthritis Index difficulty score (49 vs 45, respectively). No differences were observed between groups in ROM or function at the six-week or three-month assessment. In addition, no differences were observed for the secondary outcome measures (perceived effect, medication use, satisfaction with treatment, adherence) at either of the assessment times.

Section Summary: TKA

Numerous RCTs have compared CPM as adjunctive therapy with PT for patients undergoing TKA. Most trials used CPM in the inpatient setting and are less relevant to today’s practice patterns of shorter hospital stays followed by outpatient rehabilitation. Some of these trials reported improvements in ROM for patients receiving CPM but these improvements were short-term, of small magnitude, and of uncertain clinical significance. The RCTs that specifically evaluated CPM in the non-acute care hospital setting or home setting did not show improved outcomes with CPM.

Articular Cartilage Repair of the Knee

Although no RCTs were identified comparing health outcomes with or without the use of CPM, CPM is routinely used as part of the rehabilitation protocol for as long as six weeks when weight-bearing is restricted following autologous chondrocyte implantation.21,22,23,Basic research supports the use of CPM to facilitate greater healing of articular cartilage of full-thickness defects that penetrate the subchondral bone compared with either immobilization or intermittent mobilization.24,25,

Fazalare et al (2010) published a systematic review of CPM after knee cartilage defect surgery.26, Reviewers found that CPM had been used following autologous chondrocyte implantation, microfracture, and osteochondral autografts in numerous studies in the previous five years. Four level III (cohort) studies with 262 patients were identified that compared CPM with no CPM; no RCTs were identified. Procedures in these four studies included microfracture, periosteal transplant of the patella, and high tibial osteotomy with diagnostic arthroscopy or abrasion arthroplasty. CPM regimens ranged from six days to eight weeks. Heterogeneity in the studies and outdated surgical techniques limited conclusions drawn from these trials. Clinical outcomes did not permit a definitive conclusion of efficacy of CPM. However, reviewers cited several studies in which other outcomes (eg, histologic outcomes on follow-up biopsies) did favor CPM.

Another systematic review, by Howard et al (2010), evaluated CPM and other postoperative practices after knee cartilage repair.27, Reviewers cited several basic science studies using animal models that appear to support CPM. They identified two clinical studies, both of which were retrospective nonrandomized comparative studies. In 1 study (n=43), there were no differences between groups in clinical or functional outcomes at an average follow-up of 4.2 years. In the other study (n=77), patients in the CPM group (n=46) had greater improvement in grading of the cartilage lesion compared with patients who did not have access to CPM (n=31).

Section Summary: Articular Cartilage Repair of the Knee

Current evidence on use of CPM to facilitate knee rehabilitation after articular cartilage repair includes systematic reviews. These reviews reported methodologic issues with available cohort studies and a paucity of studies assessing clinical application of CPM to knee rehabilitation.

Other Musculoskeletal Conditions Requiring PT
Articular Knee Fractures

Hill et al (2014) randomized 40 patients with articular fractures of either the proximal part of the tibia or the distal end of the femur to standardized PT with or without CPM for 48 hours postoperatively.28, At the 48-hour assessment, the CPM group had significantly greater knee flexion (43 difference, p<0.005). However, 6 of 20 patients were unable to tolerate CPM and there was no benefit to adding 48 hours of CPM when assessed at any of the follow-up visits (2, 6, 12, 24 weeks).

Anterior Cruciate Ligament Repair

This literature review did not identify any RCTs of CPM in the home setting after repair of theACL. However, the studies of CPM after ACL repair in the immediate postoperative period may be relevant to the non-acute care hospital or home setting for patients discharged following a shorter hospital stay. The TEC Assessment (1997) concluded that CPM as an adjunct to conventional PT in the immediate postoperative period after ACL repair offered no demonstrable advantage over conventional PT alone.1, In a systematic review of ACL reconstruction rehabilitation, Wright et al (2008) discussed 6 RCTs on CPM published before 1996; no RCTs published after the 1997 TEC Assessment were identified.29, Reviewers found no substantial advantage for CPM use and concluded that CPM for ACL rehabilitation could not be justified. Wright et al (2008) also noted that most current ACL rehabilitation protocols initiate early motion within the first postoperative week.

Rotator Cuff Repair

Du Plessis et al (2011) published a systematic review of CPM following rotator cuff repair.30, Three RCTs were included, though meta-analysis could not be conducted due to heterogeneity across trials. Two of the RCTs, by Lastayo et al (1998) and Raab et al (1996) are discussed below.31,32, The third trial was a German-language report by Michael et al (2005) that found a significant reduction of 12 days in the time to reach 90 abduction compared with the PT control group, with no significant difference in pain between the 2 groups.33,

The trial by Lastayo et al (1998) randomized 31 patients undergoing rotator cuff repair to a 4-week home program of CPM (average, 3 h/d) or to manual passive elevation and rotation exercises.31, No significant difference in outcomes was observed between the twoapproaches. Previously, Raab et al (1996) had randomized 26 patients to postoperative PT alone or to PT plus CPM.32, Patients were evaluated with preoperative and three-month postoperative shoulder scores that included pain, function, muscle strength, and ROM. A statistically significant improvement was found in ROM for those receiving CPM, although there was no significant improvement in overall shoulder score between groups. Both of these RCTs were likely underpowered to show differences on important clinical outcomes.

Garofalo et al (2010) reported on a randomized trial assessing the effects of CPM after rotator cuff repair.34, During weeks 1 to 4 postsurgery, all 100 patients underwent passive self-assisted ROM exercise, with half of the patients also receiving CPM for 4, 30-minute sessions per day. The physical therapist‒supervised exercises included pendulum movements and progressive passive abduction, forward flexion, and external rotation. When patients were not exercising, the shoulder was immobilized in a sling brace. From weeks 5 to 28 postsurgery, all patients underwent the same PT protocol. ROM and VAS ratings for pain were measured at 2.5, 6, and 12 months by an independent examiner. Between groups, VAS ratings were slightly better for patients who received CPM at 2.5-month follow-up (7.5 vs 9.1) but not at the 6-month (0.5 vs 0.6) or 12-month (0.2 vs 0.2) assessments, all respectively. ROM was significantly better in the group receiving CPM vs those who did not at 2.5-month follow-up (eg, forward flexion, 133.0° vs 120.7°) and 6 months (158.1° vs 151.7°) but not at 12 months (165.2° vs 158.0°), all respectively.

Subsection Summary: Rotator Cuff Repair

Three RCTs of CPM following rotator cuff surgery were identified in the English-language literature. Two of these trials reported short-term improvements in ROM for patients undergoing CPM, and one reported a short-term reduction in pain. None reported long-term improvements or benefits in functional status. Therefore, the clinical significance of the short-term improvements reported is uncertain. In addition, there is uncertainty about the optimal PT regimen after shoulder surgery, and so the optimal comparator for CPM is not clear.

Hip Osteoarthritis

One older pilot study (1999) examined the use of CPM in patients with hip osteoarthritis in the absence of surgical intervention.35, In this uncontrolled study, CPM was used for 1.2 to 7.6 hours daily during the 12-week trial. While improvements were noted in patients’ pain assessments, a controlled trial is needed to validate this treatment effect, particularly compared with a program of regular walking.

Adhesive Capsulitis of the Shoulder

Dundar et al (2009) compared CPM with PT in a randomized trial of 57 patients with adhesive capsulitis (frozen shoulder).36, CPM or PT was provided for one hour a day (five d/wk) for four weeks. Pain and function levels were similar in the 2 groups at baseline, with VAS scores for pain ranging from 5.44 (at rest) to 6.34 (with movement). Assessments at baseline, 4, and 12 weeks showed reductions in pain and improvements in function levels for both groups. However, CPM resulted in greater pain reduction than PT (at rest, 47% vs 25%; with movement, 35% vs 21%; at night, 36% vs 19%, all respectively). There were no differences between groups in ROM or function. This trial provided modest support for the inclusion of CPM in a PT regimen for this patient population.

An RCT by Ekim et al (2016) compared CPM (n=20) with PT (n=21) for the treatment of adhesive capsulitis in patients who had diabetes.37, CPM or PT was provided for onehour a day (five d/wk) for four weeks. All patients received electrotherapy and after the four-week initial treatment phase, were instructed to continue with an eight-week at home exercise program. Outcome measures were pain (at rest, in motion, at night) and ROM (active and passive). Pain decreased significantly in both treatment groups, though patients in the CPM group reported a larger improvement in pain scores than those in the PT group. ROM improved significantly in both treatment groups as well. Patients in the CPM group reported larger improvements in abduction and flexion measures than patients in the CPM group, while external and internal rotation improvements were similar across groups.

Elbow Contracture

Postoperative management of open elbow contracture release with CPM was assessed in a matched cohort study by Lindenhovius et al (2009).38, Sixteen patients who had used CPM after open contracture release and 16 patients who had not were matched by age, sex, diagnosis, ROM, and radiographic appearance. Improvements in ROM did not differ between groups at the early (range, 4-10 months) and the final (range, 11-56 months) evaluations.

Hand Repair

The TEC Assessment (1997) reviewed a multicenter study of CPM in patients who had undergone flexor tendon repair, and found the data inadequate to permit scientific conclusions about CPM application.1,

Ring et al (1998) conducted a randomized trial that examined the role of CPM in patients undergoing silicone interposition arthroplasty of the metacarpophalangeal joints secondary to rheumatoid arthritis.39, Patients were randomized to a 6-week protocol of CPM (10 hands [40 joints]) or to a standard dynamic splint protocol (15 hands [60 joints]). The trial did not show better outcomes in the CPM group.

A retrospective chart review (2008) compared 15 patients who had received CPM after tenolysis with 21 who did not.40, Patients who received CPM improved total active motion by 40 (range, 137-177), while patients who did not improved total active motion by 32 (range, 152-184); this difference was not statistically significant.

Foot Repair

One study (2005) has compared CPM with immobilization following surgical treatment of idiopathic club foot in 37 infants (50 feet).41, The infants were randomized to CPM (4 h/d) or to casting during days 10 to 42 following surgery. Blinded analysis showed improvements in the Dimeglio Clubfoot Score with CPM (from 9.7 to 3.1) that were significantly greater than those in the control group (from 10.3 to 4.2) through 12 months (97% follow-up). Between 12 and 18 months, this trend reversed and by 48 months postsurgery, there was no significant difference between groups. Another study (2007) by the same group reported low compliance with this treatment.42,

Back Pain

An RCT by Gavish et al (2015) evaluated a CPM device for treatment of chronic low back pain in 36 patients.43, Although patients treated with the device appeared to have improved outcomes on a numeric rating scale of back pain compared with waiting-list controls, the trial had significant methodologic problems. Patients who received other treatments were excluded, a large number of subjects dropped out, and control patients did not receive any conservative management.

Section Summary: Other Musculoskeletal Conditions Requiring PT

There is a wide range of studies assessing the use of CPM for musculoskeletal conditions other than TKA and knee cartilage repair. Three small RCTs of CPM after rotator cuff surgery showed some evidence that CPM after this shoulder surgery improved short-term pain and ROM; however, the trials were not high-quality, and the small differences in outcomes may not be clinically important. Two trials reported short-term improvements in ROM for patients undergoing CPM, and one reported a short-term reduction in pain. None reported long-term improvements, and there are no reported benefits in functional status. Therefore, the clinical significance of the short-term improvements reported is uncertain. In addition, there is uncertainty about the optimal PT regimen following shoulder surgery such that the optimal treatment comparator for CPM is unclear. Two small RCTs compared CPM with conventional PT for treatment of adhesive capsulitis. One of the trials focused on diabetic patients with adhesive capsulitis. Both reported comparable improvements in ROM and functional ability between treatment groups. For other musculoskeletal conditions, RCTs do not exist; case series either did not show efficacy of CPM or had important methodologic flaws.

Stroke

CPM has been studied as a means to aid recovery of motor skills following stroke. One study (2005) randomized 35 patients to daily sessions of CPM (25 minutes) or to daily group therapy sessions consisting of self-directed ROM for poststroke rehabilitation.44, All patients also received standard poststroke therapy for 3.5 hours a day. After 20 days of therapy, there was a trend for greater shoulder joint stability in the CPM group (n=17, p=0.06) compared with the control group (n=15). No statistically significant differences were found for measures of motor impairment. This trial had a small sample size and short follow-up period.

Section Summary: Stroke

A small randomized trial has reported a trend toward improvement for the outcome of shoulder joint stability with CPM but shows no statistical difference between CPM plus PT and PT alone. This trial was small and treatment lasted only 20 days.

Summary of Evidence

For individuals who have TKA who receive CPM in the home setting, the evidence includes RCTs, case series, and systematic reviews. Therelevant outcomes are symptoms and functional outcomes. Early trials generally used CPM in the inpatient setting and are less relevant to today’s practice patterns of short hospital stays followed by outpatient rehabilitation. Current postoperative rehabilitation protocols differ considerably from when the largest body of evidence was collected, making it difficult to apply available evidence to the present situation. For use of CPM after TKA, recent studies have suggested that institutional and home use of CPM has no benefit compared with standard PT. There were no studies evaluating CPM in patients who could not perform standard PT. The evidence is insufficient to determine the effects of the technology on health outcomes.

For individuals who have articular cartilage repair of the knee who receive CPM in the home setting, the evidence includes nonrandomized studies, case series, and studies with nonclinical outcomes (eg, histology), and systematic reviews of these studies. Therelevant outcomes are symptoms and functional outcomes. Systematic reviews of CPM for this indication have cited studies reporting better histologic outcomes in patients following CPM. A few studies have reported clinical outcomes but inadequacies of these studies do not permit conclusions on efficacy. The evidence is insufficient to determine the effects of the technology on health outcomes.

For individuals who have musculoskeletal conditions other than TKA or knee cartilage repair requiring PT who receive CPM in the home setting, the evidence includes RCTs for some conditions and case series for others. Therelevant outcomes are symptoms and functional outcomes. Three small RCTs of CPM after rotator cuff surgery showed some evidence that CPM after this shoulder surgery improved short-term pain and ROM; however, the trials were not high-quality, and the small differences in outcomes may not be clinically important. Two trials reported short-term improvements in ROM for patients undergoing CPM, and one reported a short-term reduction in pain. None reported long-term improvements, and there are no reported benefits in functional status. Therefore, the clinical significance of the short-term improvements reported is uncertain. In addition, there is uncertainty about the optimal PT regimen following shoulder surgery such that the optimal treatment comparator for CPM is unclear. Two small RCTs compared CPM with conventional PT for treatment of adhesive capsulitis. One of the trials focused on diabetic patients with adhesive capsulitis. Both reported comparable improvements in ROM and functional ability between treatment groups. For other musculoskeletal conditions, RCTs do not exist; case series either did not show efficacy of CPM or had important methodologic flaws. The evidence is insufficient to determine the effects of the technology on health outcomes.

For individuals who have had a stroke requiring PT who receive CPM in the home setting, the evidence includes a small RCT. Therelevant outcomes are symptoms and functional outcomes. This trial reported a trend toward improved shoulder joint stability but no statistical difference between CPM plus PT and PT alone. The trial was small and treatment lasted only 20 days. The evidence is insufficient to determine the effects of the technology on health outcomes.

SUPPLEMENTAL INFORMATION
Clinical Input From Physician Specialty Societies and Academic Medical Centers

While the various physician specialty societies and academic medical centers may collaborate with and make recommendations during this process, through the provision of appropriate reviewers, input received does not represent an endorsement or position statement by the physician specialty societies or academic medical centers, unless otherwise noted.

2016 Input

In response to requests, input was received from 2 physician specialty societies and 1 academic medical center while this policy was under review in 2016. Input considered continuous passive motion (CPM) medically necessary as an adjunct to physical therapy during the non-weight-bearing rehabilitation period following articular cartilage repair procedures of the knee. One reviewer referred to the American Academy of Orthopaedic Surgery (2015) guidelines on the surgical management of osteoarthritis of the knee, which concluded that there was strong evidence that CPM after knee arthroplasty does not improve outcomes.

2010 Input

In response to requests, input was received from 2 physician specialty societies and 5 academic medical centers while this policy was under review in 2010. Overall, input supported the use of CPM under conditions of low postoperative mobility or inability to comply with rehabilitation exercises after total knee arthroplasty or total knee arthroplasty revision or during the non-weight-bearing rehabilitation period following articular cartilage repair procedures of the knee. Support was limited for use of CPM in joints other than the knee or in situations or conditions other than those described in this policy.

2008 Input

In response to requests, input was received from 1 physician specialty society and 2 academic medical centers while this policy was under review in 2008. The three reviewers interpreted the existing literature as supporting the use of CPM for the knee for at least seven days postoperatively, whether in the hospital or home, and suggested that longer use of CPM would be warranted for special conditions.

Practice Guidelines and Position Statements

American Academy of Orthopaedic Surgeons

TheAAOS(2015) published evidence-based guidelines on the surgical management of osteoarthritis of the knee.45,The AAOS identified two high-quality studies and five moderate-quality studies that evaluated the use ofCPM. In one high-quality study, CPM was used for about two weeks after discharge. The AAOS concluded that “the combined results provide strong evidence that the surgical outcomes for those who used continuous passive motion are not better than for those who did not use continuous passive motion.”

French Physical Medicine and Rehabilitation Society

Clinical practice guidelines from the French Physical Medicine and Rehabilitation Society (2007) concluded that evidence is not sufficient to recommend substituting CPM for other rehabilitation techniques aimed at early mobilization after total knee arthroplasty.46, The policy did not find a positive effect of CPM over intermittent early mobilization, at short- or long-term follow-up.

U.S. Preventive Services Task Force Recommendations

Not applicable.

Ongoing and Unpublished Clinical Trials

Some currently unpublished trials that might influence this review are listed in Table 2.

Table 2. Summary of Key Trials
NCT No.Trial Name
Planned Enrollment
Completion Date
Ongoing
NCT01420887Preservation of Joint Function Using Postoperative Continuous Passive Motion (CPM): A Pilot Study
50
Dec 2018
NCT: national clinical trial.]
________________________________________________________________________________________

Horizon BCBSNJ Medical Policy Development Process:

This Horizon BCBSNJ Medical Policy (the “Medical Policy”) has been developed by Horizon BCBSNJ’s Medical Policy Committee (the “Committee”) consistent with generally accepted standards of medical practice, and reflects Horizon BCBSNJ’s view of the subject health care services, supplies or procedures, and in what circumstances they are deemed to be medically necessary or experimental/ investigational in nature. This Medical Policy also considers whether and to what degree the subject health care services, supplies or procedures are clinically appropriate, in terms of type, frequency, extent, site and duration and if they are considered effective for the illnesses, injuries or diseases discussed. Where relevant, this Medical Policy considers whether the subject health care services, supplies or procedures are being requested primarily for the convenience of the covered person or the health care provider. It may also consider whether the services, supplies or procedures are more costly than an alternative service or sequence of services, supplies or procedures that are at least as likely to produce equivalent therapeutic or diagnostic results as to the diagnosis or treatment of the relevant illness, injury or disease. In reaching its conclusion regarding what it considers to be the generally accepted standards of medical practice, the Committee reviews and considers the following: all credible scientific evidence published in peer-reviewed medical literature generally recognized by the relevant medical community, physician and health care provider specialty society recommendations, the views of physicians and health care providers practicing in relevant clinical areas (including, but not limited to, the prevailing opinion within the appropriate specialty) and any other relevant factor as determined by applicable State and Federal laws and regulations.

___________________________________________________________________________________________________________________________

Index:
Continuous Passive Motion Device
CPM Device

References:
1. Blue Cross and Blue Shield Association Technology Evaluation Center (TEC). Continuous Passive Motion as an Adjunct to Physical Therapy for Joint Rehabilitation. TEC Assessments. 1997;Volume 12:Tab 20.

2. McInnes J, Larson MG, Daltroy LH, et al. A controlled evaluation of continuous passive motion in patients undergoing total knee arthroplasty. JAMA. Sep 16 1992;268(11):1423-1428. PMID 1512910.

3. Milne S, Brosseau L, Robinson V, et al. Continuous passive motion following total knee arthroplasty. Cochrane Database Syst Rev. Jun 2003(2):CD004260. PMID 12804511.

4. Brosseau L, Milne S, Wells G, et al. Efficacy of continuous passive motion following total knee arthroplasty: a metaanalysis. J Rheumatol. Nov 2004;31(11):2251-2264. PMID 15517640.

5. Harvey LA, Brosseau L, Herbert RD. Continuous passive motion following total knee arthroplasty in people with arthritis. Cochrane Database Syst Rev. Mar 17 2010(3):CD004260. PMID 20238330.

6. Harvey LA, Brosseau L, Herbert RD. Continuous passive motion following total knee arthroplasty in people with arthritis. Cochrane Database Syst Rev. Feb 6 2014;2(2):CD004260. PMID 24500904.

7. He ML, Xiao ZM, Lei M, et al. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty. Cochrane Database Syst Rev. Jul 29 2014;7(7):CD008207. PMID 25069620.

8. Yashar AA, Venn-Watson E, Welsh T, et al. Continuous passive motion with accelerated flexion after total knee arthroplasty. Clin Orthop Relat Res. Dec 1997(345):38-43. PMID 9418619.

9. MacDonald SJ, Bourne RB, Rorabeck CH, et al. Prospective randomized clinical trial of continuous passive motion after total knee arthroplasty. Clin Orthop Relat Res. Nov 2000(380):30-35. PMID 11064970.

10. Pope RO, Corcoran S, McCaul K, et al. Continuous passive motion after primary total knee arthroplasty. Does it offer any benefits? J Bone Joint Surg Br. Nov 1997;79(6):914-917. PMID 9393903.

11. Kumar PJ, McPherson EJ, Dorr LD, et al. Rehabilitation after total knee arthroplasty: a comparison of 2 rehabilitation techniques. Clin Orthop Relat Res. Oct 1996(331):93-101. PMID 8895624.

12. Bruun-Olsen V, Heiberg KE, Mengshoel AM. Continuous passive motion as an adjunct to active exercises in early rehabilitation following total knee arthroplasty - a randomized controlled trial. Disabil Rehabil. Jul 2009;31(4):277-283. PMID 18608367.

13. Denis M, Moffet H, Caron F, et al. Effectiveness of continuous passive motion and conventional physical therapy after total knee arthroplasty: a randomized clinical trial. Phys Ther. Feb 2006;86(2):174-185. PMID 16445331.

14. Leach W, Reid J, Murphy F. Continuous passive motion following total knee replacement: a prospective randomized trial with follow-up to 1 year. Knee Surg Sports Traumatol Arthrosc. Oct 2006;14(10):922-926. PMID 16489477.

15. Boese CK, Weis M, Phillips T, et al. The efficacy of continuous passive motion after total knee arthroplasty: a comparison of three protocols. J Arthroplasty. Jun 2014;29(6):1158-1162. PMID 24412145.

16. Herbold JA, Bonistall K, Blackburn M, et al. Randomized controlled trial of the effectiveness of continuous passive motion after total knee replacement. Arch Phys Med Rehabil. Jul 2014;95(7):1240-1245. PMID 24685389.

17. Chen B, Zimmerman JR, Soulen L, et al. Continuous passive motion after total knee arthroplasty: a prospective study. Am J Phys Med Rehabil. Sep-Oct 2000;79(5):421-426. PMID 10994883.

18. Herbold JA, Bonistall K, Blackburn M. Effectiveness of continuous passive motion in an inpatient rehabilitation hospital after total knee replacement: a matched cohort study. PM R. Oct 2012;4(10):719-725. PMID 22959052.

19. Worland RL, Arredondo J, Angles F, et al. Home continuous passive motion machine versus professional physical therapy following total knee replacement. J Arthroplasty. Oct 1998;13(7):784-787. PMID 9802665.

20. Lenssen TA, van Steyn MJ, Crijns YH, et al. Effectiveness of prolonged use of continuous passive motion (CPM), as an adjunct to physiotherapy, after total knee arthroplasty. BMC Musculoskelet Disord. Apr 29 2008;9:60. PMID 18442423.

21. Browne JE, Anderson AF, Arciero R, et al. Clinical outcome of autologous chondrocyte implantation at 5 years in US subjects. Clin Orthop Relat Res. Jul 2005(436):237-245. PMID 15995447.

22. Farr J. Autologous chondrocyte implantation improves patellofemoral cartilage treatment outcomes. Clin Orthop Relat Res. Oct 2007;463:187-194. PMID 17960681.

23. Rosenberger RE, Gomoll AH, Bryant T, et al. Repair of large chondral defects of the knee with autologous chondrocyte implantation in patients 45 years or older. Am J Sports Med. Dec 2008;36(12):2336-2344. PMID 18725654.

24. Nugent-Derfus GE, Takara T, O'Neill J K, et al. Continuous passive motion applied to whole joints stimulates chondrocyte biosynthesis of PRG4. Osteoarthritis Cartilage. May 2007;15(5):566-574. PMID 17157538.

25. Salter RB. The biologic concept of continuous passive motion of synovial joints. The first 18 years of basic research and its clinical application. Clin Orthop Relat Res. May 1989(242):12-25. PMID 2650945.

26. Fazalare JA, Griesser MJ, Siston RA, et al. The use of continuous passive motion following knee cartilage defect surgery: a systematic review. Orthopedics. Dec 2010;33(12):878. PMID 21162503.

27. Howard JS, Mattacola CG, Romine SE, et al. Continuous passive motion, early weight bearing, and active motion following knee articular cartilage repair: evidence for clinical practice. Cartilage. Oct 2010;1(4):276-286. PMID 26069559.

28. Hill AD, Palmer MJ, Tanner SL, et al. Use of continuous passive motion in the postoperative treatment of intra- articular knee fractures. J Bone Joint Surg Am. Jul 16 2014;96(14):e118. PMID 25031380.

29. Wright RW, Preston E, Fleming BC, et al. A systematic review of anterior cruciate ligament reconstruction rehabilitation: part I: continuous passive motion, early weight bearing, postoperative bracing, and home-based rehabilitation. J Knee Surg. Jul 2008;21(3):217-224. PMID 18686484.

30. Du Plessis M, Eksteen E, Jenneker A, et al. The effectiveness of continuous passive motion on range of motion, pain and muscle strength following rotator cuff repair: a systematic review. Clin Rehabil. Apr 2011;25(4):291-302. PMID 20943710.

31. Lastayo PC, Wright T, Jaffe R, et al. Continuous passive motion after repair of the rotator cuff. A prospective outcome study. J Bone Joint Surg Am. Jul 1998;80(7):1002-1011. PMID 9698005.

32. Raab MG, Rzeszutko D, O'Connor W, et al. Early results of continuous passive motion after rotator cuff repair: a prospective, randomized, blinded, controlled study. Am J Orthop (Belle Mead NJ). Mar 1996;25(3):214-220. PMID 8775698.

33. Michael JW, Konig DP, Imhoff AB, et al. [Efficiency of a postoperative treatment after rotator cuff repair with a continuous passive motion device (CPM)] [German]. Z Orthop Ihre Grenzgeb. Jul-Aug 2005;143(4):438-445. PMID 16118760.

34. Garofalo R, Conti M, Notarnicola A, et al. Effects of one-month continuous passive motion after arthroscopic rotator cuff repair: results at 1-year follow-up of a prospective randomized study. Musculoskelet Surg. May 2010;94 Suppl 1:S79-83. PMID 20383685.

35. Simkin PA, de Lateur BJ, Alquist AD, et al. Continuous passive motion for osteoarthritis of the hip: a pilot study. J Rheumatol. Sep 1999;26(9):1987-1991. PMID 10493681.

36. Dundar U, Toktas H, Cakir T, et al. Continuous passive motion provides good pain control in patients with adhesive capsulitis. Int J Rehabil Res. Sep 2009;32(3):193-198. PMID 19011582.

37. Ekim AA, Inal EE, Gonullu E, et al. Continuous passive motion in adhesive capsulitis patients with diabetes mellitus: A randomized controlled trial. J Back Musculoskelet Rehabil. Nov 21 2016;29(4):779-786. PMID 27002662.

38. Lindenhovius AL, van de Luijtgaarden K, Ring D, et al. Open elbow contracture release: postoperative management with and without continuous passive motion. J Hand Surg Am. May-Jun 2009;34(5):858-865. PMID 19362791.

39. Ring D, Simmons BP, Hayes M. Continuous passive motion following metacarpophalangeal joint arthroplasty. J Hand Surg Am. May 1998;23(3):505-511. PMID 9620192.

40. Schwartz DA, Chafetz R. Continuous passive motion after tenolysis in hand therapy patients: a retrospective study. J Hand Ther. Jul-Sep 2008;21(3):261-266; quiz 267. PMID 18652971.

41. Zeifang F, Carstens C, Schneider S, et al. Continuous passive motion versus immobilisation in a cast after surgical treatment of idiopathic club foot in infants: a prospective, blinded, randomised, clinical study. J Bone Joint Surg Br. Dec 2005;87(12):1663-1665. PMID 16326882.

42. Kasten P, Geiger F, Zeifang F, et al. Compliance with continuous passive movement is low after surgical treatment of idiopathic club foot in infants: a prospective, double-blinded clinical study. J Bone Joint Surg Br. Mar 2007;89(3):375-377. PMID 17356153.

43. Gavish L, Barzilay Y, Koren C, et al. Novel continuous passive motion device for self-treatment of chronic lower back pain: a randomised controlled study. Physiotherapy. Mar 2015;101(1):75-81. PMID 25280603.

44. Lynch D, Ferraro M, Krol J, et al. Continuous passive motion improves shoulder joint integrity following stroke. Clin Rehabil. Sep 2005;19(6):594-599. PMID 16180594.

45. American Academy of Orthopaedic Surgeons. Surgical managment of osteoarthritis of the knee: Evidence-based clinical practice guideline. Rosemont, IL: AAOS; 2015.

46. Postel JM, Thoumie P, Missaoui B, et al. Continuous passive motion compared with intermittent mobilization after total knee arthroplasty. Elaboration of French clinical practice guidelines. Ann Readapt Med Phys. May 2007;50(4):244-257. PMID 17412445.

47. Center for Medicare & Medicaid. National Coverage Decision (NCD) for Durable Medical Equipment Reference List (280.1). 2005; https://www.cms.gov/medicare-coverage-database/details/ncd- details.aspx?NCDId=190&bc=AgAAQAAAAAAA&ncdver=2. Accessed February 16, 2018.

Codes:
(The list of codes is not intended to be all-inclusive and is included below for informational purposes only. Inclusion or exclusion of a procedure, diagnosis, drug or device code(s) does not constitute or imply authorization, certification, approval, offer of coverage or guarantee of payment.)

CPT*

    HCPCS
      E0935
      E0936

    * CPT only copyright 2020 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.

    _________________________________________________________________________________________

    Medical policies can be highly technical and are designed for use by the Horizon BCBSNJ professional staff in making coverage determinations. Members referring to this policy should discuss it with their treating physician, and should refer to their specific benefit plan for the terms, conditions, limitations and exclusions of their coverage.

    The Horizon BCBSNJ Medical Policy Manual is proprietary. It is to be used only as authorized by Horizon BCBSNJ and its affiliates. The contents of this Medical Policy are not to be copied, reproduced or circulated to other parties without the express written consent of Horizon BCBSNJ. The contents of this Medical Policy may be updated or changed without notice, unless otherwise required by law and/or regulation. However, benefit determinations are made in the context of medical policies existing at the time of the decision and are not subject to later revision as the result of a change in medical policy

    ____________________________________________________________________________________________________________________________